PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could breast cancer patients avoid surgery? new trial tests less treatment
Disease control Recruiting nowThis study is for people with certain types of breast cancer (HER2-positive or triple-negative) who have a complete response to initial drug therapy. It tests whether they can safely skip surgery and only receive radiation, or skip radiation if surgery shows no cancer left. For a…
Matched conditions: PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Breast cancer drug's skin side effects under the microscope
Knowledge-focused Recruiting nowThis study looks at how aromatase inhibitor therapy changes skin quality and self-esteem in breast cancer survivors. Researchers will use skin imaging and surveys to track changes in 35 women starting this hormone therapy. The goal is to better understand and manage these side ef…
Matched conditions: PROGESTERONE RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC